
|Videos|January 16, 2014
Marine Compound Discovery Shows Promise of Improved Drug Treatment for COPD Patients
University of Florida pharmacy researchers have isolated a compound from blue-green algae that may inhibit the progression of pulmonary disease.
Advertisement
University of Florida pharmacy researchers have isolated a compound from blue-green algae that may inhibit the progression of pulmonary disease.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
2
Amid Mounting Pressure, FDA Commissioner Marty Makary to Resign
3
From Misdiagnosis to Advocacy: Addressing Bias and Equity in Heart Failure Management
4
Q&A: Pharmacist-Led Strategies to Help Improve Diabetes Outcomes and Lower Costs
5


































































































































